Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains

Molecular Brain Research

Volumn 43, Issue 1-2, 1996, Pages 85-95

  Johnston, Janet A ^a   Norgren, Svante ^b,c   Ravid, Rivka ^d   Wasco, Wilma ^e   Winblad, Bengt ^a   Lannfelt, Lars ^a   Cowburn, Richard F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NETHERLANDS BRAIN BANK   (Netherlands)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Amyloid precursor like protein 2; mRNA; Post mortem human brain; Solution hybridisation RNase protection

Indexed keywords

AMYLOID PRECURSOR LIKE PROTEIN 2; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; DNA; ISOPROTEIN; MESSENGER RNA; PROTEINASE INHIBITOR; RIBONUCLEASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DNA CONTENT; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RNA ANALYSIS; RNA RNA HYBRIDIZATION;

EID: 18844467196     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00161-1     Document Type: Article

References (67)

1. Blangy, A., Vidal, F., Cuzin, F., Yang, Y.-H., Boulukos, K. and Rassoulzadegan, M., CDEBP, a site-specific DNA-binding protein of the "APP-like" family, is required during the early development of the mouse, J. Cell Sci., 108 (1995) 675-683.
2. Bowen, D.M., Smith, C.B., White, P., Flack, R.H.A., Carrasco, L.H., Gedye, J.L. and Davison, A.N., Chemical pathology of the dementias, Brain, 100 (1977) 427-453.
3. Burke, W.J., O'Malley, K.L., Chung, H.D., Harmon, S.K., Miller, J.P. and Berg, L., Effect of pre- and postmortem variables on specific mRNA levels in human brain, Mol. Brain Res., 11 (1991) 37-41.
4. Bush, A.I., Beyreuther, K. and Masters, C.L., βA4 amyloid protein and its precursor in Alzheimer's disease, Pharmacol. Ther., 56 (1992) 97-117.
5. Citron, M., Vigo-Pelfrey, C., Teplow, D.B., Miller, C., Schenk, D., Johnston, J., Winblad, B., Venizelos, N., Lannfelt, L. and Selkoe, D.J., Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer's disease mutation, Proc. Natl. Acad. Sci. USA, 91 (1994) 11993-11997.
6. Clark, A.W., Krekoski, C.A., Parhad, I.M., Liston, D., Julien, J.-P. and Hoar, D.I., Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex, Ann. Neurol., 25 (1989) 331-338.
7. Cohen, M.L., Golde, T.E., Usiak, M.F., Younkin, L.H. and Younkin, S.G., In situ hybridisation of nucleus basalis neurons shows increased β-amyloid mRNA in Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 85 (1988) 1227-1231.
8. Corder, E.H., Saunders, A.H., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261 (1993) 921-923.
9. Durnam, D.M. and Palmiter, R.D., A practical approach for quantitating specific mRNAs by solution hybridisation, Anal. Biochem., 131 (1983) 385-393.
10. Elliott, R.C., Inturrisi, C.E., Black, I.B. and Dreyfus, C.F., An improved method detects differential NGF and BDNF gene expression in response to depolarization in cultured hippocampal neurons, Mol. Brain Res., 26 (1994) 81-88.
11. Forsell, C. and Lannfelt, L., Amyloid precursor protein mutation at codon 713 (Ala-Val) does not cause schizophrenia: non-pathogenic variant found at codon 705 (silent), Neurosci. Lett., 184 (1995) 90-93.
12. Goedert, M., Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease, EMBO J., 6 (1987) 3627-3632.
13. Golde, T.E., Estus, S., Usiak, M., Younkin, L.H. and Younkin, S.G., Expression of β-amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR, Neuron, 4 (1990) 253-267.
14. Goldgaber, D., Lerman, M.I., McBride, O.W., Saffiotti, U. and Gajdusek, D.C., Characterization and chromosomal location of a cDNA encoding brain amyloid of Alzheimer's disease, Science, 235 (1987) 877-880.
15. Goodison, K.L., Parhad, I.M., White, III, C.L., Sima, A.A.F. and Clark, A.W., Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease, J. Neuropathol. Exp. Neurol., 52:3 (1993) 192-198.
16. Hardy, J. and Allsop, D., Amyloid deposition as the central event in the aetiology of Alzheimer's disease, Trends Pharmacol. Sci., 12 (1991) 383-388.
17. Hardy, J.A., Wester, P., Winblad, B., Gezelius, C., Bring, G. and Eriksson, A., The patients dying after long terminal phase have acidotic brains: implications for biochemical measurements on autopsy tissue, J. Neural Transm., 61 (1985) 253-264.
18. Harrison, P.J., Barton, A.J.L. and Pearson, R.C.A., Expression of amyloid beta-protein precursor mRNAs in familial Alzheimer's disease, NeuroReport, 2 (1991) 152-154.
19. Harrison, P.J., Barton, A.J.L., Procter, A.W., Bowen, D.M. and Pearson, R.C.A., The effects of Alzheimer's disease, other dementias, and premortem course on β-amyloid precursor protein messenger RNA in frontal cortex, J. Neurochem., 62 (1994) 635-644.
20. Higgins, G.A., Lewis, D.A., Bahmanyar, S., Goldgaber, D., Gajdusek, D.C., Young, W.G., Morrison, J.H. and Wilson, M.C., Differential regulation of amyloid-β-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 85 (1988) 1297-1301.
21. Hyman, B.T., Wenniger, J.J. and Tanzi, R.E., Nonisotopic in situ hybridization of amyloid beta protein precursor in Alzheimer's disease: expression in neurofibrillary tangle bearing neurons and in the microenvironment surrounding senile plaques, Mol. Brain Res., 18 (1993) 253-258.
22. Jacobsen, J.S., Blume, A.J. and Vitek, M.P., Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer's disease and normal brain by S1 nuclease protection analysis, Neurobiol. Aging, 12 (1991) 585-592.
23. Johnson, S.A., McNeill, T., Cordell, B. and Finch, C.E., Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease, Science, 248 (1990) 854-857.
24. Johnson, S.A., Pasinetti, G.M., May, P.C., Ponte, P.A., Cordell, B. and Finch, C.E., Selective reduction of mRNA for the β-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains, Exp. Neurol., 102 (1988) 264-268.
25. Johnson, S.A., Rogers, J. and Finch, C.E., APP-695 transcript prevalence is selectively reduced during Alzheimer's disease in cortex and hippocampus but not in cerebellum, Neurobiol. Aging, 10 (1989) 267-272.
26. Johnston, J.A., Cowburn, R.F., Norgren, S., Wiehager, B., Venizelos, N., Winblad, B., Vigo-Pelfrey, C., Schenk, D., Lannfelt, L. and O'Neill, C., Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation, FEBS Lett., 354 (1994) 274-278.
27. Johnston, J.A., Norgren, S., Anneren, G., Cowburn, R.F. and Lannfelt, L., A new quantitative solution hybridisation-RNase protection assay for APP and APLP2 mRNA, Mol. Brain Res., 43 (1996) 77-84.
28. Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K. and Müller-Hill, B., The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature, 325 (1987) 733-736.
29. Kingsbury, A.E., Foster, O.J.F., Nisbet, A.P., Cairns, N., Bray, L., Eve, D.J., Lees, A.J. and Marsden, C.D., Tissue pH as an indicator of mRNA preservation in human post-mortem brain, Mol. Brain Res., 28 (1995) 311-318.
30. Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S. and Ito, H., Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity, Nature, 331 (1988) 530-532.
31. König, G., Mönning, U., Czech, C., Prior, R., Banati, R., Schreiter-Gasser, U., Bauer, J., Masters, C. and Beyreuther, K., Identification and differential expression of a novel alternative splice isoform of the βA4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells, J. Biol. Chem., 267 (1992) 10804-10809.
32. König, G., Salbaum, J.M., Wiestler, O., Lang, W., Schmitt, H.P., Masters, C. and Beyreuther, K., Alternative splicing of the βA4 amyloid gene of Alzheimer's disease in cortex of control and Alzheimer's disease patients, Mol. Brain Res., 9 (1991) 259-262.
33. Kroczek, R.A. and Siebert, E., Optimization of Northern analysis by vacuum blotting, RNA-transfer visualisation, and ultraviolet fixation, Anal. Biochem., 184 (1990) 90-95.
34. Labarca, C. and Paigen, K., A simple, rapid, and sensitive DNA assay procedure, Anal. Biochem., 102 (1980) 344-352.
35. McKhann, G., Drachmann, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease, Neurology, 34 (1984) 939-944.
36. Mönning, U., König, G., Banati, R.B., Mechler, H., Czech, C., Gehrmann, J., Schreiter-Gasser, U., Masters, C.L. and Beyreuther, K., Alzheimer βA4-amyloid protein precursor in immunocompetent cells, J. Biol. Chem., 267 (1992) 23950-23956.
37. Morrison, M.R., Pardue, S., Maschoff, K., Griffin, W.S.T., White, III, C.L., Gilbert, J. and Roses, A., Brain messenger RNA levels and ribonuclease activity in Alzheimer's disease, Biochem. Soc. Trans., 15 (1986) 133-134.
38. Neve, R.L., Rodgers, J. and Higgins, G.A., The Alzheimer amyloid precursor-related transcript lacking the β/A4 sequence is specifically increased in Alzheimer's disease brain, Neuron, 5 (1990) 329-338.
39. Norgren, S., Arner, P. and Luthman, H., Insulin receptor ribonucleic acid levels and alternative splicing in human liver, muscle, and adipose tissue: tissue specificity and relation to insulin action, J. Clin. Endocrinol. Metab., 78:3 (1994) 757-762.
40. Norgren, S., Zierath, J., Galuska, D., Wallberg-Henriksson, H. and Luthman, H., Differences in the ratio of RNA encoding two isoforms of the insulin receptor between control and NIDDM patients, Diabetes, 42 (1993) 675-681.
41. Oyama, F., Shimada, H., Oyama, R. and Ihara, Y., Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population, Mol. Brain Res., 29 (1995) 92-98.
42. Palmert, M.R., Golde, T.E., Cohen, M.L., Kovacs, D.M., Tanzi, R.E., Gusella, J.F., Usiak, M.F., Younkin, L.H. and Younkin, S.G., Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease, Science, 241 (1988) 1080-1084.
43. Pearson, R.C.A. and Powell, T.P.S., The neuroanatomy of Alzheimer's disease, Rev. Neurosci., 2 (1989) 101-122.
44. Ponte, P., Gonzalez-De Whitt, P., Schilling, J., Miller, J., Hsu, D., Greenberg, B., Davis, K., Wallace, W., Lieberburg, I., Fuller, F. and Cordell, B., A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors, Nature, 331 (1988) 525-527.
45. Ravid, R. and Swaab, D.F., The Netherlands Brain Bank - a clinicopathological link in aging and dementia research, J. Neural Transm., Suppl. 39 (1993) 143-153.
46. Robakis, N.K., Ramakrishna, N., Wolfe, G. and Wisniewski, H.M., Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides, Proc. Natl. Acad. Sci. USA, 84 (1987) 4190-4194.
47. Robinson, C.A., Clark, A.W., Parhad, I.M., Fung, T.S. and Bou, S.S., Gene expression in Alzheimer neocortex as a function of age and pathologic severity, Neurobiol. Aging, 15 (1994) 681-690.
48. Rockenstein, E.M., McConlogue, L., Tan, H., Power, M., Masliah, E. and Mucke, L., Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease, J. Biol. Chem., 270 (1995) 28257-28267.
49. Sandbrink, R., Masters, C.L. and Beyreuther, K., Similar alternative splicing of a non-homologous domain in βA4-amyloid protein precursor-like proteins, J. Biol. Chem., 269 (1994) 14227-14234.
50. Saunders, A.M., Strittmatter, W.J., Schmechel, D., St George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D. and Roses, A.D., Association of apolipoprotein allele ε4 with late-onset familial and sporadic Alzheimer disease, Neurology, 43 (1993) 1467-1472.
51. Schechter, R., Yen, S.H.C. and Terry, R.D., Fibrous astrocytes in senile dementia of the Alzheimer type, J. Neuropathol. Exp. Neurol., 40 (1981) 95-101.
52. Scott, S.A., Johnson, S.A., Zarow, C. and Perlmutter, L.S., Inability to detect beta-amyloid protein precursor mRNA in Alzheimer plaque-associated microglia, Exp. Neurol., 121 (1993) 113-118.
53. Selkoe, D.J., Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease, Annu. Rev. Cell Biol., 10 (1994) 373-403.
54. Slunt, H.H., Thinakaran, G., Von Koch, C., Lo, A.C.Y., Tanzi, R.E. and Sisodia, S.S., Expression of an ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP), J. Biol. Chem., 269 (1994) 2637-2644.
55. Spillantini, M.G., Hunt, S.P., Ulrich, J. and Goedert, M., Expression and cellular localization of amyloid β-protein precursor transcripts in normal human brain and in Alzheimer's disease, Mol. Brain Res., 6 (1989) 143-150.
56. Sprecher, C.A., Grant, F.J., Grimm, G., O'Hara, P.J., Norris, F., Norris, K. and Foster, D.C., Molecular cloning of the cDNA for a human amyloid precursor protein homolog: evidence for a multigene family, Biochemistry, 32 (1993) 4481-4486.
57. Suzuki, N., Cheung, T.T., Cai, X.-D., Odaka, A., Otvos, Jr., L., Eckman, C., Golde, T.E. and Younkin, S.G., An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants, Science, 264 (1994) 1336-1340.
58. Tanaka, S., Liu, L., Kimura, J., Shiojiri, S., Takahashi, Y., Kitaguchi, N., Nakamura, S. and Ueda, K., Age-related changes in the proportion of amyloid precursor protein mRNAs in Alzheimer's disease and other neurological disorders, Mol. Brain Res., 15 (1992) 303-310.
59. Tanaka, S., Shiojiri, S., Takahashi, Y., Kitaguchi, N., Ito, H., Kameyama, M., Kimura, J., Nakamura, S. and Ueda, K., Tissue-specific expression of three types of β-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer's disease brain, Biochem. Biophys. Res. Commun., 165 (1989) 1406-1414.
60. Tanzi, R.E., Gusella, J.F., Watkins, P.C., Bruns, G.A.P., St George-Hyslop, P., Van Keuren, M.L., Patterson, D., Pagan, S., Kurnit, D.M. and Neve, R.L., Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus, Science, 235 (1987) 880-884.
61. Tanzi, R.E., McClatchey, A.I., Lamperti, E.D., Villa-Komaroff, L., Gusella, J.F. and Neve, R.L., Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease, Nature, 331 (1988) 528-530.
62. Tanzi, R.E., Wenniger, J.J. and Hyman, B.T., Cellular specificity and regional distribution of amyloid β protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation, Mol. Brain Res., 18 (1993) 246-252.
63. Wasco, W., Bupp, K., Magendantz, M., Gusella, J.F., Tanzi, R.E. and Solomon, F., Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid β protein precursor, Proc. Natl. Acad. Sci. USA, 89 (1992) 10758-10762.
64. Wasco, W., Gurubhagavatula, S., De Paradis, M., Romano, D.M., Sisodia, S.S., Hyman, B.T., Neve, R.L. and Tanzi, R.E., Isolation and characterisation of APLP2 encoding a homologue of the Alzheimer's associated amyloid β protein precursor, Nature Genet., 5 (1993) 95-100.
65. Webster, M.-T., Groome, N., Francis, P.T., Pearce, B.R., Sherriff, F.E., Thinakaran, G., Felsenstein, K.M., Wasco, W., Tanzi, R.E. and Bowen, D.M., A novel protein, amyloid precursor-like protein 2, is present in human brain, cerebrospinal fluid and conditioned media, Biochem. J., 310 (1995) 95-99.
66. Wighton-Benn, W., Vardy, E., Heath, P.R. and Pearson, R.C.A., Alterations in messenger RNA's encoding major isoforms of amyloid precursor protein in Alzheimer's disease neocortex, Soc. Neurosci. Abstr., 21 (1995) 85.4.
67. Yan, Y.C., Bai, Y., Wang, L., Miao, S. and Koide, S.S., Characterisation of cDNA encoding a human sperm membrane protein related to the A4 amyloid protein, Proc. Natl. Acad. Sci. USA, 87 (1990) 2405-2408.